MON-LB101 Pharmacokinetics of Liothyronine during Thyroid Hormone Therapy Withdrawal

Background Liothyronine (LT3) is a substitute for levothyroxine (LT4) for thyroid cancer patients during the preparation for nuclear medicine procedures, and there is renewed interest in its use in combination with LT4 in patients who do not respond to the standard treatment. This therapy is commonl...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Endocr Soc
Huvudupphovsmän: Celi, Francesco, Wohlford, George, Linderman, Joyce, Smith, Sheila, Yavuz, Sahzene, Pucino, Frank, Van Tassell, Benjamin
Materialtyp: Artigo
Språk:Inglês
Publicerad: Endocrine Society 2019
Ämnen:
Thyroid
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6550962/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-MON-LB101
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk